Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial

Franco Citterio, M Salvadori, Mp Scolari, E Bertoni, P Rigotti, M Cossu, A Dal Canton, G Tisone, A Albertazzi, F Pisani, G Gubbiotti, G Piredda, G Busnach, V Sparacino, V Goepel, P Messa, P Berloco, D Montanaro, P Veroux, S FedericoM Bartezaghi, G Corbetta, C. Ponticelli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

81 Citazioni (Scopus)

Abstract

In combination with everolimus (EVL), cyclosporine A (CsA) may be used at low exposure, so reducing the risk of renal dysfunction in renal transplant recipients (RTR). We evaluated whether higher exposure of EVL could allow a further reduction of CsA.
Lingua originaleEnglish
pagine (da-a)1194-1202
Numero di pagine9
RivistaTransplantation
Volume88
DOI
Stato di pubblicazionePubblicato - 2009

Keywords

  • Adolescent
  • Adult
  • Aged
  • Confidence Intervals
  • Creatinine
  • Cyclosporine
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents
  • Kidney Transplantation
  • Living Donors
  • Middle Aged
  • Patient Compliance
  • Patient Selection
  • Sirolimus
  • Survival Analysis
  • Treatment Outcome
  • Triglycerides
  • Young Adult

Fingerprint

Entra nei temi di ricerca di 'Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial'. Insieme formano una fingerprint unica.

Cita questo